Saroja Pharma Industries India Limited (SAROJA) — corporate announcements
Saroja Pharma Industries India Limited
$SAROJA
Saroja Pharma Industries India is engaged in amongst the leading traders, exporter and suppliers of Specialty Chemicals. The offered range is widely praised for its superior effectiveness, shelf life and perfect composition
SAROJA PHARMA's board approved key management changes. Mr. Pulinattu Damodaran Nandakumar is re-designated as Whole-time Director. The board also appointed Mr. Niraj Variava, a Chartered Accountant, as Internal Auditor for FY2026-27.
Saroja Pharma's Board approved the financial results for the half-year and financial year ended March 31, 2026. Auditors issued an unmodified opinion. The trading window for insiders opens 48 hours post-results.